Hormone therapy is widely used to treat menopausal symptoms such as hot flashes and night sweats. But scientists have long ...

Evoke and Evoke+ -- the randomized, double-blind, placebo-controlled phase 3 trials conducted across 566 sites in 40 ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Eye imaging may help distinguish ALS from Alzheimer’s disease by revealing differences in retinal protein deposits using polarized light.

In TODAY.com's Expert Tip of The Day, a neurologist explains how playing games that build cognitive speed can protect against dementia for decades.

A study in the journal Neurology has shown that people with type 1 diabetes are three times more likely to develop dementia ...

Small actions today can help reduce your dementia risk.

GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...

Researchers say a simple blood test could help flag which older women face a higher risk of dementia long before any symptoms ...

"Advances in biomarker technology, digital cognitive assessments, and amyloid-targeting therapies have redefined the opportunities for accurate and early diagnosis and care of Alzheimer's disease," ...

Alzheimer’s disease is the most common cause of dementia, a condition that slowly damages memory, thinking ability, and daily functioning. Millions of people around the world live with Alzheimer’s, ...